Mir-223 Reverses the Resistance of EGFR-TKIs Through IGF1R/PI3K/Akt Signaling Pathway
International Journal of Oncology（2016）
Key words
EGFR-TKI sigma,miR-223,erlotinib,non-small cell lung cancer,lung cancer stem-like cells
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined